The study found that the inclusion of the CD28-binding site not only eliminated the need for external co-stimulation, but also prolonged T cell survival, improved recognition of MM cells, reduced non-specific toxicity, and contributed significantly to anti-tumor efficacy. The gene discussed is CD28; the disease is neoplasm.